Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moschos

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Next steps in immuno-oncology: enhancing antitumor effects through appropriate patient selection and rationally designed combination strategiesA K S Salama, S J Moschos
Genes & Cancer|July 23, 2011
Functional analysis and molecular targeting of aurora kinases a and B in advanced melanomaXiaolei Wang, Stergios J Moschos, Dorothea Becker
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
MelanomaStergios J Moschos, Panagiotis A Konstantinopoulos, John M Kirkwood
Journal of the National Cancer Institute|June 12, 2008
Resolving "kinks" of chemotherapy in melanomaStergios J Moschos, Preet M Chaudhary, John M Kirkwood
Journal of Postgraduate Medicine|July 12, 2005
Mortality of percutaneous endoscopic gastrostomy in the UKG I Leontiadis, J Moschos, T Cowper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2003
Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2bStergios J Moschos, John M Kirkwood, Panagiotis A Konstantinopoulos
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|March 29, 2006
Follow up of patient with totally resected gastric stromal tumorD Tzilves, J Moschos, D Paikos, et al.
Nature Clinical Practice. Oncology|December 19, 2008
Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?John M Kirkwood, Hussein A Tawbi, Ahmad A Tarhini, et al.
Cancer Treatment Reviews|March 7, 2016
Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysisTomohiro F Nishijima, Hyman B Muss, Shlomit S Shachar, et al.
Oncology (Williston Park, N.Y.)|October 12, 2007
Integrins and cancerStergios J Moschos, Laura M Drogowski, Shelley L Reppert, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Next steps in immuno-oncology: enhancing antitumor effects through appropriate patient selection and rationally designed combination strategiesA K S Salama, S J Moschos
Genes & Cancer|July 23, 2011
Functional analysis and molecular targeting of aurora kinases a and B in advanced melanomaXiaolei Wang, Stergios J Moschos, Dorothea Becker
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
MelanomaStergios J Moschos, Panagiotis A Konstantinopoulos, John M Kirkwood
Journal of the National Cancer Institute|June 12, 2008
Resolving "kinks" of chemotherapy in melanomaStergios J Moschos, Preet M Chaudhary, John M Kirkwood
Journal of Postgraduate Medicine|July 12, 2005
Mortality of percutaneous endoscopic gastrostomy in the UKG I Leontiadis, J Moschos, T Cowper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2003
Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2bStergios J Moschos, John M Kirkwood, Panagiotis A Konstantinopoulos
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|March 29, 2006
Follow up of patient with totally resected gastric stromal tumorD Tzilves, J Moschos, D Paikos, et al.
Nature Clinical Practice. Oncology|December 19, 2008
Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?John M Kirkwood, Hussein A Tawbi, Ahmad A Tarhini, et al.
Cancer Treatment Reviews|March 7, 2016
Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysisTomohiro F Nishijima, Hyman B Muss, Shlomit S Shachar, et al.
Oncology (Williston Park, N.Y.)|October 12, 2007
Integrins and cancerStergios J Moschos, Laura M Drogowski, Shelley L Reppert, et al.
Pageof 9